Your browser doesn't support javascript.
loading
Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.
Khan, Sana; Bolton, W Kline.
Affiliation
  • Khan S; Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
  • Bolton WK; Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia wkb5s@virginia.edu.
Clin J Am Soc Nephrol ; 9(6): 1001-4, 2014 Jun 06.
Article in En | MEDLINE | ID: mdl-24855281
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, Membranous / Cyclophosphamide / Immunosuppressive Agents / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, Membranous / Cyclophosphamide / Immunosuppressive Agents / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2014 Document type: Article Country of publication: United States